New translational possibilities for microenvironmental modulation of radiosensitivity

Radiation Research

Volumn 176, Issue 3, 2011, Pages 412-414

  Glazer, Peter M ^a   Le, Quynh Thu ^b   Bristow, Rob ^c   Helleday, Thomas ^d   Pelroy, Richard ^e   Bernhard, Eric J ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; RAD51 PROTEIN;

CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; DNA REPAIR; DRUG MECHANISM; HEAD AND NECK CANCER; HUMAN; HYPOXIA; NONHUMAN; NOTE; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT RESPONSE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; CELL HYPOXIA; DNA REPAIR; HUMANS; NEOPLASMS; PROTEIN BIOSYNTHESIS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION;

EID: 80052163329     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RRXX33.1     Document Type: Note

References (21)

1. Glazer PM, Grandis J, Powell SN, Brown JM, Helleday R, Powis G. Radiation resistance in cancer therapy: meeting summary and research opportunities. Radiat Res 2011; 176:e0016-e0021.
2. Olcina M, Lecane PS, Hammond EM. Targeting hypoxic cells through the DNA damage response. Clin Cancer Res 2010; 16:5624-9.
3. Pires IM, Bencokova Z, Milani M, Folkes LK, Li JL, Stratford MR, et al. Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. Cancer Res 2010; 70:925-35.
4. Bindra RS, Glazer PM. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene 2007; 26:2048-57. (Pubitemid 46514738)
5. Klein TJ, Glazer PM. The tumor microenvironment and DNA repair. Semin Radiat Oncol 2010; 20:282-7.
6. Chan N, Pires IM, Bencokova Z, Coackley C, Luoto KR, Bhogal N, et al. Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment. Cancer Res 2010; 70:8045-54.
7. Chan N, Koritzinsky M, Zhao H, Bindra R, Glazer PM, Powell S, et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res 2008; 68:605-14. (Pubitemid 351380090)
8. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 2008; 8:425-37. (Pubitemid 351744964)
9. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118:3930-42.
10. RischinD,PetersLJ,O'SullivanB, Giralt J, FisherR, YuenK, et al. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. J Clin Oncol 2010; 28:2989-95.
11. Hill RP. Targeted treatment: insights from studies of osteopontin and hypoxia. Lancet Oncol 2005; 6:733-4. (Pubitemid 41430698)
12. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010; 120:694-705.
13. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8z T cells: changing strategies for cancer treatment. Blood 2009; 114:589-95.
14. Takeshima T, Chamoto K, Wakita D, Ohkuri T, Togashi Y, Shirato H, et al. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res 2010; 70:2697-706.
15. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005; 7:575-89. (Pubitemid 40799250)
16. Wheeler DL, Dunn EF, Harari PM. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 2010; 7:493-507.
17. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju Y, Milas L, et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNAdependent protein kinase. J Biol Chem 2005; 280:31182-9. (Pubitemid 41291855)
18. Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, et al. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci Signal 2010; 3:ra13.
19. Maity A, Bernhard EJ. Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy. Cancer Res 2010; 70:2141-5.
20. Hegan DC, Lu Y, Stachelek GC, Crosby ME, Bindra RS, Glazer PM. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc Natl Acad Sci USA 2010; 107:2201-6.
21. Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, et al. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res 2010; 70:4972-81.